← Leaderboards
Damien Thevenin
Lehigh University
$2,380,406
Attributed
$4,905,671
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,905,671 · 6
By mechanism
R01$3,298,017 · 2
R21$1,607,654 · 4
Top collaborators
- Matthew J Lazzara6 shared
- Alexey Ladokhin3 shared
- Douglas J Tobias3 shared
- Marcos M. Pires2 shared
- Matthew K Robinson2 shared
- Adam Snook2 shared
Most similar at Lehigh University
Same institution · by research overlap
- Adam Snook$401,369
- Kenneth P Kodama$1,315,031
- Derick G Brown$1,015,651
- Clay J Naito$1,517,037
- Anand Jagota$3,030,731
Others in their field
Top investigators on “Peptides”
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- John M Lachin · George Washington University$118,672,444
- David Heimbrook · Leidos Biomedical Research, Inc.$91,429,616
- Michael W Weiner · Northern California Institute Res &Educ$78,425,041
- Paul S. Aisen · Cognition Therapeutics, Inc.$69,846,203
- Rolf Apweiler · European Molecular Biology Laboratory$56,677,991
Research focus
PeptidesTumorDesignCellsCancer CellInsightMalignant NeoplasmsResistanceBaseFamilyVariantRegulationAffectPlayMolecularLeadMembraneCell LineComplementOncogenicResponseMeasurementProteinsBiology
Grant awards (17)
Elucidating the Molecular Mechanisms of Conformational Switching during Protein Insertion into Membranes$476,330
R01 · FY2025 · GM
Elucidating the Molecular Mechanisms of Conformational Switching during Protein Insertion into Membranes$476,330
R01 · FY2024 · GM
Elucidating the Molecular Mechanisms of Conformational Switching during Protein Insertion into Membranes$601,893
R01 · FY2023 · GM
Promoting Receptor Protein Tyrosine Phosphatase Activity by Targeting Transmembrane Domain Interactions$395,072
R01 · FY2023 · GM · contact PI
Chemical Remodeling of Cell Surface to Enhance the Accumulation of Therapeutic Bacteria to Tumors$213,775
R21 · FY2023 · CA
Off-the-shelf CAR-T Therapy via Tumor-Selective Immuno-engagers$209,722
R21 · FY2023 · CA · contact PI
Promoting Receptor Protein Tyrosine Phosphatase Activity by Targeting Transmembrane Domain Interactions$90,505
R01 · FY2023 · GM · contact PI
Promoting Receptor Protein Tyrosine Phosphatase Activity by Targeting Transmembrane Domain Interactions$396,263
R01 · FY2022 · GM · contact PI
Chemical Remodeling of Cell Surface to Enhance the Accumulation of Therapeutic Bacteria to Tumors$197,477
R21 · FY2022 · CA
Off-the-shelf CAR-T Therapy via Tumor-Selective Immuno-engagers$191,901
R21 · FY2022 · CA · contact PI
Promoting Receptor Protein Tyrosine Phosphatase Activity by TargetingTransmembrane Domain Interactions$63,570
R01 · FY2022 · GM · contact PI
Promoting Receptor Protein Tyrosine Phosphatase Activity by Targeting Transmembrane Domain Interactions$397,420
R01 · FY2021 · GM · contact PI
Promoting Receptor Protein Tyrosine Phosphatase Activity by Targeting Transmembrane Domain Interactions$400,634
R01 · FY2020 · GM · contact PI
RPTP domains regulating homodimerization and EGFR activity via heterodimerization$161,411
R21 · FY2017 · CA · contact PI
RPTP domains regulating homodimerization and EGFR activity via heterodimerization$211,914
R21 · FY2016 · CA · contact PI
Selective Delivery of Monomethyl Auristatin Derivatives to Prostate Tumors Using$223,808
R21 · FY2015 · CA · contact PI
Selective Delivery of Monomethyl Auristatin Derivatives to Prostate Tumors Using$197,646
R21 · FY2014 · CA · contact PI